Clinical Pharmacology in Renal Disease Flashcards
If renal function is impaired then in terms of clinical pharmacology what will there be a buildup of?
- Active drug
- Toxic or active metabolites
What 2 features would a drug have for there to be no problem between impaired renal function and pharmacology?
High therapeutic index
Low toxicity
(e.g. benzylpenicillin)
Certain drugs have a narrow therapeutic index which can lead to toxicity and death; what are the specific possible effects of these drugs: gentamicin, digoxin, lithium, tacrolimus
Gentamicin = may cause renal or ototoxicity
Digoxin = may cause arrythmia, nausea or death
Lithium = renal toxicity and death
Tacrolimus = renal and CNS toxicity
What factors found in hospital patients will interact to generate de novo renal impairment or worsen pre-existing renal impairment/toxicity?
Patients are:
- Sick*
- Volume depleted*
- Hypotensive*
- Prescribed a large number of potentially reno-toxic agents*
Mechanism of renal excretion; changes in what parameters of kidney physiology (due to disease, age or drug therapy) will automatically change drug pharmacokinetics and pharmacodynamics?
- Glomerular filtration
- Passive tubular reabsorption
- Active tubular secretion
All drugs and their metabolites are filtered at the glomerulus, renal impairment will do what to drugs cleared by this route?
Prolong their half-life
(reduction in GFR reduces clearance of drugs by the kidney resulting in accumulation; protein binding is also reduced)
What 3 things must be done with drugs when they have effects with renal impairment?
- REDUCE DOSAGE
- Increase dose interval
- TDM monitor blood levels for toxic drugs like gentamicin, lithium, digoxin, vancomycin
How does renal disease alter the actions of drugs on tissues in terms of: blood brain barrier, circulatory volume, tendency to bleed
- BBB becomes more permeable + brain becomes more sensitive to tranquilisers, sedative and opiates
- Circulatory vol may be reduced making the patient sensitive to antihypertensive agents ACEIs or alpha-blockers
- Increased tendency to bleed (beware warfarin or NSAIDs)
In patients with renal disease how do the direct nephrotoxic actions of drugs work?
Synergistically (e.g. gentamicin toxicity may be unmasked when used in conjunction with furosemide or lithium)
Renal impairment may lead to: dramatic alterations in pharmacokinetics; alteration in pharmacodynamics; increased sensitivity to the toxic effects of combined therapy - here is a more detailed summary:
When prescribing in patients with impaired renal function, what 4 things should be considered? What should be done?
Consider:
- risk/benefit ratio
- severity of possible side effects
- severity of toxicity
- availability of TDM
Do: reduce dose, change dose freq, change the drugs
Ideally if a patient suffers from renal impairment, we should should use drugs which have which 2 features?
- Have a high therapeutic index
- Are metabolised by the liver with the production of non-toxic metabolites
What is the relationship between hypertension and renal disease?
Hypertension causes renal damage
Renal damage causes hypertension
What is the dilema associated with treating hypertension in patients with renal disease?
–Normally use thiazide-type diuretics, CCBs, ACEIs
–However patients with renal impairment have a low GFR, hyperuricaemia,
–More sensitive to the hypotensive actions of antihypertensive agents.
What are the 2 ways we can tackle to problem of treating hypertension in renally impaired patients?
- Use drugs which are totally metabolised by the liver or elsewhere in the body (e.g. ACEI (but can be nephrotoxic))
- Use reduced dose of the drugs with longer dosing periods i.e. atenolol 25mg/day or on alternate days
What is the problem with using direct vasodilators for hypertension?
Can produce profound hypotension and salt + water retention
What is a possible problem with using thiazide/thiazide-type diuretics to treat hypertension?
May precipitate gout
If a drug is primarily cleared by the kidney, what will happen to it as it moves from the glomerulus along the renal tubules?
It will become increasingly concentrated
The concentrated drug exposes the kidney tissue to far greater drug concentration per surface area